GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accuray Inc (FRA:XEJ) » Definitions » Additional Paid-In Capital

Accuray (FRA:XEJ) Additional Paid-In Capital : €518.8 Mil(As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Accuray Additional Paid-In Capital?


Accuray's quarterly additional paid-in capital declined from Sep. 2023 (€522.5 Mil) to Dec. 2023 (€514.6 Mil) but then increased from Dec. 2023 (€514.6 Mil) to Mar. 2024 (€518.8 Mil).

Accuray's annual additional paid-in capital increased from Jun. 2021 (€460.4 Mil) to Jun. 2022 (€513.9 Mil) but then declined from Jun. 2022 (€513.9 Mil) to Jun. 2023 (€512.5 Mil).


Accuray Additional Paid-In Capital Historical Data

The historical data trend for Accuray's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accuray Additional Paid-In Capital Chart

Accuray Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 473.77 484.62 460.38 513.88 512.52

Accuray Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 515.43 512.52 522.54 514.64 518.84

Accuray Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Accuray Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Accuray's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Accuray (FRA:XEJ) Business Description

Traded in Other Exchanges
Address
1240 Deming Way, Madison, WI, USA, 53717
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Accuray (FRA:XEJ) Headlines

No Headlines